Berikutnya

Putar otomatis

Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD

6 Tampilan • 07/30/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis